ONCO
Onconetix
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
ONCO Profile
Onconetix, Inc.
A biotech company that develops vaccines to treat influenza and mosquito-borne diseases
201 E. Fifth Street, Suite 1900, Cincinnati, OH 45202
--
Onconetix, Inc., was incorporated in Delaware on October 26, 2018. The Company is a commercial-stage biotechnology company focused on the research, development and commercialization of oncology proprietary therapies, diagnostics and services for clinicians and patients. The company currently owns EntadFi, an FDA-approved oral treatment for benign prostatic hyperplasia (BPH), a prostate disease, and Proclarix, an advanced proprietary diagnostic system for screening and diagnosing men with indeterminate prostate-specific antigen (PSA) assessment in prostate cancer oncology.